Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04PMA
|
|||
| Former ID |
DNC004651
|
|||
| Drug Name |
1,1,1-Trifluoro-tridecan-2-one
|
|||
| Synonyms |
1,1,1-trifluorotridecan-2-one; CHEMBL90308; 86571-23-5; 1,1,1-Trifluoro-tridecan-2-one; CTK2I3319; DTXSID20571888; 2-Tridecanone, 1,1,1-trifluoro-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H23F3O
|
|||
| Canonical SMILES |
CCCCCCCCCCCC(=O)C(F)(F)F
|
|||
| InChI |
1S/C13H23F3O/c1-2-3-4-5-6-7-8-9-10-11-12(17)13(14,15)16/h2-11H2,1H3
|
|||
| InChIKey |
ZSPZNVMNSATHGF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 86571-23-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.